Pierre Weiss,Eva Mathieu,Jérôme Guicheux,Patricia Lemarchand
申请号：
US14123286
公开号：
US20140161775A1
申请日:
2012.06.04
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention relates to the use of an hydrogel comprising silylated biomolecule for the three-dimensional culture of cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and to an aqueous composition comprising i) cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and ii) a hydrogel comprising silylated biomolecule, for use for treating heart failure, in particular heart failure following myocardial infarction.
